Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Analyst Ratings

• Total Analysts: n/a
• Consensus Rating: n/a
• Price Target: n/a
• Upside: n/a

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $199,800 → $106,560	Strong Buy	Maintains	$199,800 → $106,560	+1,165,764.33%	Sep 23, 2024
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $40,439,520 → $11,721,600	Buy	Maintains	$40,439,520 → $11,721,600	+128,244,976.59%	May 13, 2022
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Maintains $37,509,120 → $29,304,000	Strong Buy	Maintains	$37,509,120 → $29,304,000	+320,612,591.47%	May 28, 2021
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $18,754,560 → $40,439,520	Buy	Maintains	$18,754,560 → $40,439,520	+442,445,414.22%	Nov 11, 2020
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates $98,461,440	Strong Buy	Initiates	$98,461,440	+1,077,258,543.33%	Apr 11, 2018
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Initiates $57,435,840	Buy	Initiates	$57,435,840	+628,400,775.27%	Sep 9, 2016